Metabolomic endotype of asthma

Journal of Immunology

Volumn 195, Issue 2, 2015, Pages 643-650

  Comhair, Suzy A A ^a,b   McDunn, Jonathan ^c   Bennett, Carole ^a   Fettig, Jade ^b   Erzurum, Serpil C ^a,b   Kalhan, Satish C ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c METABOLON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BILE ACID; CORTICOSTEROID; INTERLEUKIN 6; INTERLEUKIN 8; IPRATROPIUM BROMIDE; LATHOSTEROL; LEUKOTRIENE RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE; SCATTER FACTOR; TAURINE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CHOLESTEROL; GLYCODEOXYCHOLIC ACID; NITRIC OXIDE; TAUROCHOLIC ACID;

ADULT; AMINO ACID METABOLISM; ANTIBODY SPECIFICITY; ARTICLE; ASTHMA; BRONCHOCONSTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREGULATION; MALE; METABOLOME; METABOLOMICS; PEAK EXPIRATORY FLOW; PILOT STUDY; PRIORITY JOURNAL; PROTEIN METABOLISM; RESPIRATORY TRACT INFLAMMATION; TANDEM MASS SPECTROMETRY; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; EXHALATION; LUNG; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADENOSINE MONOPHOSPHATE; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BILE ACIDS AND SALTS; BIOMARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; EXHALATION; FEMALE; GLYCODEOXYCHOLIC ACID; HUMANS; LUNG; MALE; METABOLOME; METABOLOMICS; NIACINAMIDE; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TAURINE; TAUROCHOLIC ACID;

EID: 84936817781     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500736     Document Type: Article

References (42)

1. Comhair, S. A., and S. C. Erzurum. 2010. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 12: 93-124.
2. Busse, W., J. Elias, D. Sheppard, and S. Banks-Schlegel. 1999. Airway remodeling and repair. Am. J. Respir. Crit. Care Med. 160: 1035-1042.
3. Calhoun, W. J., H. E. Reed, D. R. Moest, and C. A. Stevens. 1992. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 145: 317-325.
4. NO) for clinical applications. Am. J. Respir. Crit. Care Med. 184: 602-615.
5. Dweik, R. A., D. Laskowski, M. Ozkan, C. Farver, and S. C. Erzurum. 2001. High levels of exhaled nitric oxide (NO) and NO synthase III expression in lesional smooth muscle in lymphangioleiomyomatosis. Am. J. Respir. Cell Mol. Biol. 24: 414-418.
6. Dweik, R. A., R. L. Sorkness, S. Wenzel, J. Hammel, D. Curran-Everett, S. A. Comhair, E. Bleecker, W. Busse, W. J. Calhoun, M. Castro, et al; National Heart, Lung, and Blood Institute Severe Asthma Research Program. 2010. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am. J. Respir. Crit. Care Med. 181: 1033-1041.
7. Erzurum, S. C., and B. M. Gaston. 2012. Biomarkers in asthma: A real hope to better manage asthma. Clin. Chest Med. 33: 459-471.
8. Woodruff, P. G., B. Modrek, D. F. Choy, G. Jia, A. R. Abbas, A. Ellwanger, L. L. Koth, J. R. Arron, and J. V. Fahy. 2009. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180: 388-395.
9. Dweik, R. A., S. A. Comhair, B. Gaston, F. B. Thunnissen, C. Farver, M. J. Thomassen, M. Kavuru, J. Hammel, H. M. Abu-Soud, and S. C. Erzurum. 2001. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc. Natl. Acad. Sci. USA 98: 2622-2627.
10. Evans, A. M., C. D. DeHaven, T. Barrett, M. Mitchell, and E. Milgram. 2009. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem. 81: 6656-6667.
11. Gibney, M. J., M. Walsh, L. Brennan, H. M. Roche, B. German, and B. van Ommen. 2005. Metabolomics in human nutrition: opportunities and challenges. Am. J. Clin. Nutr. 82: 497-503.
12. Kalhan, S. C., L. Guo, J. Edmison, S. Dasarathy, A. J. McCullough, R. W. Hanson, and M. Milburn. 2011. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60: 404-413.
13. Wishart, D. S. 2007. Current progress in computational metabolomics. Brief. Bioinform. 8: 279-293.
14. American Thoracic Society. 2000. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am. J. Respir. Crit. Care Med. 162: 2341-2351.
15. Cowan, D. C., D. R. Taylor, L. E. Peterson, J. O. Cowan, R. Palmay, A. Williamson, J. Hammel, S. C. Erzurum, S. L. Hazen, and S. A. Comhair. 2015. Biomarker-based asthma phenotypes of corticosteroid response. J. Allergy Clin. Immunol. 135: 877-, e1.
16. Michils, A., S. Baldassarre, and A. Van Muylem. 2008. Exhaled nitric oxide and asthma control: A longitudinal study in unselected patients. Eur. Respir. J. 31: 539-546.
17. Kalhan, S. C., L. L. Gruca, P. S. Parimi, A. O'Brien, L. Dierker, and E. Burkett. 2003. Serine metabolism in human pregnancy. Am. J. Physiol. Endocrinol. Metab. 284: E733-E740.
18. John, K., S. Wielgosz, K. Schulze-Osthoff, H. Bantel, and R. Hass. 2013. Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome. Cell Death Dis. 4: e886.
19. Ripps, H., and W. Shen. 2012. Review: taurine: A "very essential" amino acid. Mol. Vis. 18: 2673-2686.
20. Hofford, J. M., L. Milakofsky, S. Pell, J. E. Fish, S. P. Peters, M. Pollice, and W. H. Vogel. 1997. Levels of amino acids and related compounds in bron-choalveolar lavage fluids of asthmatic patients. Am. J. Respir. Crit. Care Med. 155: 432-435.
21. Santangelo, F., J. Cortijo, and E. Morcillo. 2003. Taurine and the lung: which role in asthma? Adv. Exp. Med. Biol. 526: 403-410.
22. Bridges, C. C., M. S. Ola, P. D. Prasad, A. El-Sherbeny, V. Ganapathy, and S. B. Smith. 2001. Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells. Am. J. Physiol. Cell Physiol. 281: C1825-C1836.
23. Koo, T. S., H. J. Kwon, M. H. Kim, D. D. Kim, C. K. Shim, S. J. Chung, and S. Chong. 2012. Functional impairment of rat taurine transporter by activation of nitrogen oxide through superoxide. Drug Metab. Pharmacokinet. 27: 286-293.
24. Comhair, S. A., W. Xu, S. Ghosh, F. B. Thunnissen, A. Almasan, W. J. Calhoun, A. J. Janocha, L. Zheng, S. L. Hazen, and S. C. Erzurum. 2005. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am. J. Pathol. 166: 663-674.
25. Marozkina, N. V., and B. Gaston. 2015. Nitrogen chemistry and lung physiology. Annu. Rev. Physiol. 77: 431-452.
26. Watts, J., J. Segieth, B. Pearce, and P. S. Whitton. 2004. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats. Neurosci. Lett. 357: 179-182.
27. Lambert, I. H. 2004. Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem. Res. 29: 27-63.
28. 2 isoforms in swelling-and melittin-induced arachidonic acid release and taurine efflux in NIH3T3 fibroblasts. Am. J. Physiol. Cell Physiol. 291: C1286-C1296.
29. Schonhoff, C. M., U. Ramasamy, and M. S. Anwer. 2011. Nitric oxide-mediated inhibition of taurocholate uptake involves S-nitrosylation of NTCP. Am. J. Physiol. Gastrointest. Liver Physiol. 300: G364-G370.
30. Trauner, M., A. Mennone, A. Gigliozzi, F. Fraioli, and J. L. Boyer. 1998. Nitric oxide and guanosine 39, 59-cyclic monophosphate stimulate bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units. Hepatology 28: 1621-1628.
31. v nitroarginine, by less synthesis of bile acids. Biosci. Biotechnol. Biochem. 62: 773-777.
32. Sansbury, B. E., A. Bhatnagar, and B. G. Hill. 2014. Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice. Front Physiol 5: 453.
33. Miettinen, T. A., and H. Gylling. 2003. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur. J. Clin. Invest. 33: 976-982.
34. Wu, A. H., W. Ruan, J. Todd, and K. L. Lynch. 2014. Biological variation of b-sitosterol, campesterol, and lathosterol as cholesterol absorption and synthesis biomarkers. Clin. Chim. Acta 430: 43-47.
35. + metabolism in health and disease. Trends Biochem. Sci. 32: 12-19.
36. Aksoy, P., T. A. White, M. Thompson, and E. N. Chini. 2006. Regulation of intracellular levels of NAD: A novel role for CD38. Biochem. Biophys. Res. Commun. 345: 1386-1392.
37. 2/2 mouse. Biochem. Biophys. Res. Commun. 346: 188-192.
38. Deshpande, D. A., S. Dogan, T. F. Walseth, S. M. Miller, Y. Amrani, R. A. Panettieri, and M. S. Kannan. 2004. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am. J. Respir. Cell Mol. Biol. 31: 36-42.
39. 2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J. 17: 452-454.
40. Guedes, A. G., D. A. Deshpande, M. Dileepan, T. F. Walseth, R. A. Panettieri, Jr., S. Subramanian, and M. S. Kannan. 2015. CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models. Can. J. Physiol. Pharmacol. 93: 145-153.
41. Anderson, G. P. 2008. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372: 1107-1119.
42. Lötvall, J., C. A. Akdis, L. B. Bacharier, L. Bjermer, T. B. Casale, A. Custovic, R. F. Lemanske, Jr., A. J. Wardlaw, S. E. Wenzel, and P. A. Greenberger. 2011. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 127: 355-360.